Join leading experts for an insightful virtual panel discussion that explores how precision medicine has the potential to transform obesity care.

Obesity is a complex disease, influenced by genetic, behavioral, metabolic, and environmental factors. Traditional treatments often fall short due to a one-size-fits-all approach. Precision medicine approaches and frameworks offer tantalizing potential to transform obesity care by tailoring treatments to each patient's unique health profile, paving the way for enhanced effectiveness and fewer side effects.

This webinar will explore the advances in treatment from GLP-1 agonists to the future of personalized obesity treatment plans, while addressing critical topics such as:

Why Obesity Is Hard to Treat: Understanding the causes and challenges in managing obesity.

GLP-1 Medications in Care Plans: How these drugs are incorporated into personalized treatment strategies.

Who Should Use GLP-1 Medications: Identifying the right candidates for this treatment.

Overcoming Challenges: Addressing access issues, insurance hurdles, long-term use, and related health impacts.

What’s Next After GLP-1s: Exploring future innovations in obesity treatment.

Our panel of thought leaders in obesity treatment and precision medicine includes:

Andres Acosta, MD, PhD, Associate Professor of Medicine, Co-Director of Nutrition Obesity Research Center, and Director of Precision Medicine for Obesity Program, Mayo Clinic

Jaime Almandoz, MD, Medical Director, Weight Wellness Program, and Associate Professor of Internal Medicine, University of Texas Southwestern Medical Center

Noor Khan, MD, Associate Program Director, UPMC Obesity Medicine Fellowship Program

David Rometo, MD, Clinical Director, UPMC Center for Obesity Medicine, and Clinical Associate Professor of Medicine, University of Pittsburgh

The Future of Obesity Treatment: Is There Opportunity Beyond GLP-1s?